Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia
Authors:
- 6 August 2016
- journal article
- research article
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 48 (1) , 27-34
Abstract
Patient selection and timing of percutaneous left ventricular assist device (pLVAD) insertion for maximal benefit during ventricular tachycardia (VT) ablation is not well defined. We aimed to assess the outcomes of pre-emptive and rescue use of pLVAD during VT ablation in patients with ischemic and non-ischemic cardiomyopathy. Between January 2009 and October 2011, 93 patients underwent VT ablation. Three groups were compared: (1) Rescue group (n = 12)—patients who required emergent pLVAD insertion due to hemodynamic collapse during VT ablation, (2) Pre-emptive group (n = 24)—patients who had pre-ablation pLVAD insertion, and (3) Non-pLVAD group (n = 57)—patients who did not undergo pLVAD insertion. Procedural outcomes including 30-day mortality were compared. Thirty-day mortality was higher in the Rescue group compared to the Pre-emptive group (58 vs. 4 %, p = 0.003) and non-pLVAD (58 vs. 3 %, p = 0.001) group. There was no significant difference in 30-day mortality or long-term freedom of VT between the pre-emptive and non-pLVAD groups. Despite rescue pLVAD insertion, hemodynamic collapse during VT ablation is associated with a persistently high 30-day mortality. Further studies are warranted to predict hemodynamic collapse and to refine the role of pLVAD in this setting.Keywords
This publication has 21 references indexed in Scilit:
- Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group studyHeart Rhythm, 2015
- Current status of percutaneous ventricular assist devices for cardiogenic shockCurrent Opinion in Cardiology, 2011
- The Percutaneous Ventricular Assist Device in Severe Refractory Cardiogenic ShockJACC, 2011
- Use of the Impella™ Microaxial Blood Pump for Ablation of Hemodynamically Unstable Ventricular TachycardiaJournal of Cardiovascular Electrophysiology, 2010
- Catheter Ablation of Recurrent Scar‐Related Ventricular Tachycardia Using Electroanatomical Mapping and Irrigated Ablation Technology: Results of the Prospective Multicenter Euro‐VT‐StudyJournal of Cardiovascular Electrophysiology, 2009
- Percutaneous left ventricular assist devices during cardiogenic shock and high-risk percutaneous coronary interventionsCurrent Cardiology Reports, 2009
- A Prospective Feasibility Trial Investigating the Use of the Impella 2.5 System in Patients Undergoing High-Risk Percutaneous Coronary Intervention (The PROTECT I Trial)JACC: Cardiovascular Interventions, 2009
- Ablation of Ventricular Tachycardia in Patients with Structural Heart DiseasePacing and Clinical Electrophysiology, 2008
- Percutaneous Endocardial and Epicardial Ablation of Hypotensive Ventricular Tachycardia with Percutaneous Left Ventricular Assist in the Electrophysiology LaboratoryJournal of Cardiovascular Electrophysiology, 2006
- A New Technique to Perform Epicardial Mapping in the Electrophysiology LaboratoryJournal of Cardiovascular Electrophysiology, 1996